More than acinar identity? A novel cystic phenotype suggests broader roles for NR5A2 in pancreatic cancer †
Open Access
- 14 January 2021
- journal article
- editorial
- Published by Wiley in The Journal of Pathology
- Vol. 254 (1), 1-4
- https://doi.org/10.1002/path.5619
Abstract
The prognosis for pancreatic ductal adenocarcinoma (PDAC) remains dismal. Multiple genome wide association studies (GWAS) have implicated the nuclear receptor NR5A2 in modulating PDAC risk, but mechanisms for this association are not understood. NR5A2 is a transcription factor that maintains acinar cell identity, and heterozygous loss of Nr5a2 in mice accelerates oncogenic KRAS‐driven formation of pancreatic intraepithelial neoplasia (PanIN), a PDAC precursor derived from acinar cells. In a recent issue of The Journal of Pathology, Cobo et al. characterize a novel mouse model that uses Ptf1a:Cre to drive oncogenic Kras as well as heterozygous Nr5a2 inactivation. In addition to the expected PanIN lesions, these mice exhibited a surprising phenotype: large pancreatic cystic lesions which have not been previously reported. Comparing expression of oncogenic Kras and heterozygous Nr5a2 in various mouse models reveals several possible explanations for these cystic lesions. Importantly, these differences across mouse models suggest that NR5A2 may contribute to PDAC precursors in ways beyond its previously characterized acinar cell autonomous role. These observations highlight that pathways implicated by GWAS may have roles in unexpected cell types, and an understanding of these roles will be critical to guide new preventive and treatment strategies for PDAC.Funding Information
- National Pancreas Foundation
- National Institutes of Health (R03 DK122232, K08 DK105326)
This publication has 12 references indexed in Scilit:
- Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells’ heterogeneityNature Communications, 2020
- The orphan nuclear receptor LRH-1/NR5a2 critically regulates T cell functionsScience Advances, 2019
- Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreasNature, 2018
- Liver receptor homolog-1 (NR5a2) regulates CD95/Fas ligand transcription and associated T-cell effector functionsCell Death & Disease, 2017
- Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous NeoplasmClinical and Translational Gastroenterology, 2017
- The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinomaeLife, 2015
- The nuclear hormone receptor family member NR5A2 controls aspects of multipotent progenitor cell formation and acinar differentiation during pancreatic organogenesisDevelopment, 2014
- Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiationGut, 2013
- Nr5a2heterozygosity sensitises to, and cooperates with, inflammation inKRasG12V-driven pancreatic tumourigenesisGut, 2013
- Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferationProceedings of the National Academy of Sciences of the United States of America, 2011